Pharm-Olam's response to COVID-19 from CEO Rob Davie, PhD. Read Here

Request a Proposal  

Learning Center

Filter by Type:

Filter by Topic:

Sort by:
Resource
Case Study

Accuracy and Compliance in a Phase I/II Trial Involving Preterm Neonates

A Pharm-Olam case study of a Phase I/II pediatric Respiratory Distress Syndrome neonate study with a gestational age between 27 and 33 weeks.

2 min. Read

Resource
Case Study

Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

In this Phase III study, Pharm-Olam partnered with a progressive sponsor company to assist in finding a better solution for suffering with ...

3 min. read

Resource
Case Study

Acute Bacterial Skin and Skin Structure Infection (ABSSSI)

Pharm-Olam provided a complete enrollment solution for the management and data submission of this Acute Bacterial Skin and Skin Structure ...

2 min. Read

Resource
Case Study

Allergic Rhinitis

A Pharm-Olam overview of Allergic Rhinitis based on two decades of study experience.

2 min. read

Resource
eBook

Analyzing The Systemic Lupus Erythematosus Competitive Landscape

In this white paper we cover key events in lupus history as well as the current ...

10 min. Read

Resource
Webinar

CIO's Perspectives: Driving Clinical Trial Innovation with a Unified Platform

Watch the webinar and learn how clinical research is shifting from developing blockbuster drugs for everyone, to more targeted therapies that ...

60 min. watch

Be the first to read our new learning center articles.

We'll only send you one email a month featuring our best content from the month before.

Subscribe to the Learning Center
Be the first to read our new learning center articles.